Press releases

- Dementia: Combination of “Feelings” and Measurements Suggest Alzheimer’s in the Early Stage

The MRI.

New evidence on subjective impairments in cognitive performance

Read more

- “Hartwig Piepenbrock-DZNE Prize” Honors Research on Brain Diseases

Michel Goedert

Neuroscientist Michel Goedert from Cambridge, UK, has received the "Hartwig Piepenbrock DZNE Prize", which is endowed with 60,000 euros.

Read more

- Alzheimer's: Amyloid and Tau Are a Perilous Couple

DZNE study provides new insights into pathological phenomena of Alzheimer‘s disease.

Read more

- European Partnership between Academia and Pharma to Study SCA3 Ataxia

Image shows gait analysis in clinical research.

A European research consortium led by DZNE will be investigating the neurodegenerative disease “Spinocerebellar Ataxia Type 3” (SCA3) in collaboration with the French pharmaceutical company Servier Laboratories.

Read more

- Alzheimer’s: Protective Immune Cells Active Decades Before Symptom Onset

symbol image mri

In individuals with a genetic predisposition to Alzheimer’s disease, the immune cells of the brain – the “microglia” – start exerting a protective effect up to two decades before the first symptoms appear.


Read more

- The Retina as a Potential Biomarker for Reduced Brain Matter

Cross-section through the human retina showing its different layers.

A study by DZNE and the University Hospital Bonn suggests that assessments of the eye’s retina could help to detect a loss of brain substance, i. e. “brain atrophy”.

Read more

- Alzheimer‘s: Researchers Investigate Drug Candidates against „Tau Aggregates“

Research lab, symbol image,

DZNE scientist Markus Zweckstetter has been awarded 150,000 euros by the European Research Council to test potential drugs against Alzheimer’s disease in laboratory studies.


Read more

- Highly Responsive Immune Cells Seem to be Beneficial for the Brain

Microglia cells under the microscope.

Findings by DZNE researchers and partners support the view that hyperactive immune cells in the brain can have a protective effect in the course of neurodegenerative diseases.


Read more

- A Nationwide Study: Does PET Help with “Unclear Dementia”?

Symbolic image, not for editorial use.

A consortium led by DZNE has been tasked with investigating whether patients with “dementia of unclear etiology” benefit from examination of the brain using amyloid PET.

Read more

- State-of-the-art Brain Scanner for Dementia Research Starts Operation in Rostock

The scanner is intended in particular for research into the early diagnosis and treatment of dementia.

Read more

Welcome to our website, here you can inform yourself basically cookie-free.

We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.

Your browser allows the setting of cookies: